Positive News SentimentPositive NewsNASDAQ:NATR Nature's Sunshine Products (NATR) Stock Price, News & Analysis → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free NATR Stock Alerts $15.60 -0.01 (-0.06%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$15.41▼$15.8250-Day Range$15.51▼$20.8752-Week Range$10.69▼$21.72Volume66,946 shsAverage Volume70,363 shsMarket Capitalization$292.19 millionP/E Ratio18.35Dividend YieldN/APrice Target$24.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Nature's Sunshine Products alerts: Email Address Nature's Sunshine Products MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside53.8% Upside$24.00 Price TargetShort InterestHealthy0.50% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.63Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.67 out of 5 starsMedical Sector249th out of 920 stocksPharmaceutical Preparations Industry106th out of 427 stocks 3.5 Analyst's Opinion Consensus RatingNature's Sunshine Products has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNature's Sunshine Products has only been the subject of 1 research reports in the past 90 days.Read more about Nature's Sunshine Products' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.50% of the float of Nature's Sunshine Products has been sold short.Short Interest Ratio / Days to CoverNature's Sunshine Products has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nature's Sunshine Products has recently decreased by 19.54%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNature's Sunshine Products does not currently pay a dividend.Dividend GrowthNature's Sunshine Products does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NATR. Previous Next 3.7 News and Social Media Coverage News SentimentNature's Sunshine Products has a news sentiment score of 1.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Nature's Sunshine Products this week, compared to 1 article on an average week.Search Interest4 people have searched for NATR on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Nature's Sunshine Products to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nature's Sunshine Products insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.70% of the stock of Nature's Sunshine Products is held by insiders.Percentage Held by Institutions79.40% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Nature's Sunshine Products' insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nature's Sunshine Products is 18.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.13.Price to Earnings Ratio vs. SectorThe P/E ratio of Nature's Sunshine Products is 18.35, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 111.58.Price to Book Value per Share RatioNature's Sunshine Products has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Nature's Sunshine Products' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. About Nature's Sunshine Products Stock (NASDAQ:NATR)Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.Read More NATR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NATR Stock News HeadlinesMay 10, 2024 | finance.yahoo.comEarnings Miss: Nature's Sunshine Products, Inc. Missed EPS By 29% And Analysts Are Revising Their ForecastsMay 9, 2024 | finance.yahoo.comNature's Sunshine Products First Quarter 2024 Earnings: EPS Misses ExpectationsMay 8, 2024 | msn.comNature's Sunshine Products, Inc. (NASDAQ:NATR) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comNature’s Sunshine Products, Inc. (NASDAQ:NATR) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comNatures Sunshine Products Inc (NATR) (Q1 2024) Earnings Call Transcript Highlights: Robust ...May 8, 2024 | americanbankingnews.comNature's Sunshine Products (NASDAQ:NATR) Stock Price Passes Above 200-Day Moving Average of $18.13May 7, 2024 | msn.comNATR Stock Earnings: Natures Sunshine Products Misses EPS, Misses Revenue for Q1 2024May 7, 2024 | finance.yahoo.comNature's Sunshine (NASDAQ:NATR) Reports Q1 In Line With ExpectationsMay 7, 2024 | sfgate.comNature's Sunshine: Q1 Earnings SnapshotMay 7, 2024 | finance.yahoo.comNature’s Sunshine Reports Strong First Quarter 2024 ResultsMay 7, 2024 | globenewswire.comNature's Sunshine Reports Strong First Quarter 2024 ResultsApril 29, 2024 | finanznachrichten.deNature's Sunshine Products, Inc.: Nature's Sunshine Recognized with Six Stevie Awards in the 2024 American Business AwardsApril 29, 2024 | globenewswire.comNature's Sunshine Recognized with Six Stevie Awards in the 2024 American Business AwardsApril 26, 2024 | finance.yahoo.comSome Shareholders May Object To A Pay Rise For Nature's Sunshine Products, Inc.'s (NASDAQ:NATR) CEO This YearApril 26, 2024 | investorplace.comWhat Is the Best $20 Stock to Buy in April? 3 Top Picks.April 24, 2024 | prnewswire.comNature's Sunshine's Impact Report Highlights Achievements and Continued Commitment Toward SustainabilityApril 23, 2024 | finance.yahoo.comNature’s Sunshine Sets First Quarter 2024 Conference Call for Tuesday, May 7, 2024, at 5:00 p.m. ETApril 23, 2024 | globenewswire.comNature's Sunshine Sets First Quarter 2024 Conference Call for Tuesday, May 7, 2024, at 5:00 p.m. ETApril 21, 2024 | finance.yahoo.comThose who invested in Nature's Sunshine Products (NASDAQ:NATR) five years ago are up 126%April 4, 2024 | finance.yahoo.comNature's Sunshine Products, Inc.'s (NASDAQ:NATR) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?March 15, 2024 | finance.yahoo.comNature's Sunshine Products, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsMarch 14, 2024 | marketwatch.comNature's Sunshine Shares Touch 52-Week High After 4Q UpdateMarch 13, 2024 | finance.yahoo.comWhy Nature's Sunshine (NATR) Stock Is Up TodayMarch 13, 2024 | finanznachrichten.deNature's Sunshine Products, Inc.: Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsMarch 12, 2024 | finance.yahoo.comNature's Sunshine (NASDAQ:NATR) Misses Q4 Sales TargetsSee More Headlines Receive NATR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/12/2024Today5/17/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPersonal Products Current SymbolNASDAQ:NATR CUSIP63902710 CIK275053 Webwww.naturessunshine.com Phone(801) 341-7900Fax801-342-4305Employees814Year FoundedN/APrice Target and Rating Average Stock Price Target$24.00 High Stock Price Target$24.00 Low Stock Price Target$24.00 Potential Upside/Downside+53.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.85 Trailing P/E Ratio18.35 Forward P/E RatioN/A P/E GrowthN/ANet Income$15.08 million Net Margins3.69% Pretax Margin5.18% Return on Equity10.59% Return on Assets6.76% Debt Debt-to-Equity Ratio0.01 Current Ratio2.33 Quick Ratio1.42 Sales & Book Value Annual Sales$445.32 million Price / Sales0.66 Cash Flow$1.58 per share Price / Cash Flow9.88 Book Value$8.53 per share Price / Book1.83Miscellaneous Outstanding Shares18,730,000Free Float17,850,000Market Cap$292.19 million OptionableOptionable Beta0.85 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Terrence O. Moorehead (Age 61)President, CEO & Director Comp: $2.12MMr. L. Shane Jones (Age 53)Executive VP, CFO & Treasurer Comp: $1.01MMr. Martin Gonzalez (Age 54)Executive Vice President of Global Supply Chain Operations Comp: $690.73kTrent McCauslandExecutive Director, Head of Operations & COOMr. Nathan G. Brower (Age 43)Executive VP, General Counsel & Secretary Ms. Sarah Crockett (Age 41)Global Chief Marketing Officer Ms. Tracee Comstock (Age 58)Senior Vice President of Global Human Resources Mr. Bryant J. Yates (Age 51)Executive VP & President of Europe Comp: $496.15kMr. Daniel C. Norman (Age 49)Executive VP & President of Asia/Pacific (APAC) Comp: $574.31kMr. Kevin R. Herbert (Age 57)Executive VP & President of North America More ExecutivesKey CompetitorsVeruNASDAQ:VERUVentyx BiosciencesNASDAQ:VTYX23andMeNASDAQ:MECorMedixNASDAQ:CRMDRani TherapeuticsNASDAQ:RANIView All CompetitorsInsiders & InstitutionsKennedy Capital Management LLCSold 2,628 shares on 5/16/2024Ownership: 0.977%Ancora Advisors LLCSold 6,666 shares on 5/16/2024Ownership: 0.359%Jacobs Levy Equity Management Inc.Bought 927 shares on 5/16/2024Ownership: 0.312%California State Teachers Retirement SystemSold 845 shares on 5/16/2024Ownership: 0.007%Lazard Asset Management LLCBought 998 shares on 5/15/2024Ownership: 0.038%View All Insider TransactionsView All Institutional Transactions NATR Stock Analysis - Frequently Asked Questions Should I buy or sell Nature's Sunshine Products stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NATR shares. View NATR analyst ratings or view top-rated stocks. What is Nature's Sunshine Products' stock price target for 2024? 1 brokers have issued 1 year price objectives for Nature's Sunshine Products' stock. Their NATR share price targets range from $24.00 to $24.00. On average, they predict the company's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 53.8% from the stock's current price. View analysts price targets for NATR or view top-rated stocks among Wall Street analysts. How have NATR shares performed in 2024? Nature's Sunshine Products' stock was trading at $17.29 at the start of the year. Since then, NATR shares have decreased by 9.8% and is now trading at $15.60. View the best growth stocks for 2024 here. When is Nature's Sunshine Products' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our NATR earnings forecast. How were Nature's Sunshine Products' earnings last quarter? Nature's Sunshine Products, Inc. (NASDAQ:NATR) posted its quarterly earnings data on Tuesday, March, 12th. The company reported $0.45 earnings per share for the quarter. The company earned $108.94 million during the quarter. Nature's Sunshine Products had a trailing twelve-month return on equity of 10.59% and a net margin of 3.69%. What guidance has Nature's Sunshine Products issued on next quarter's earnings? Nature's Sunshine Products updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $455.0 million-$480.0 million, compared to the consensus revenue estimate of $467.9 million. What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO? 13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com. Terrence Moorehead has an approval rating of 86% among the company's employees. What other stocks do shareholders of Nature's Sunshine Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL) and Global Blood Therapeutics (GBT). Who are Nature's Sunshine Products' major shareholders? Nature's Sunshine Products' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.51%), Wasatch Advisors LP (2.75%), Hillsdale Investment Management Inc. (1.14%), Kennedy Capital Management LLC (0.98%), State Board of Administration of Florida Retirement System (0.38%) and Ancora Advisors LLC (0.36%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower and Wynnefield Partners Small Cap. View institutional ownership trends. How do I buy shares of Nature's Sunshine Products? Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NATR) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nature's Sunshine Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
